Gratitude Can Boost Your Health AND Your Wealth
 |
| By Chris Graebe |
Harvard published a study last year that linked longevity with being thankful all year long.
It wasn’t a big reduction in mortality risk (9%).
But what’s interesting to me is how gratitude made a difference, regardless of participants’ physical and mental health.
I got to thinking about that study because it’s Thanksgiving.
And because I am so grateful for the opportunity to serve you.
Your interest in pre-IPO opportunities means I get to travel the country and hunt for startup deals that can change investors’ lives.
Not the big, Wall Street guys who can spend half a billion dollars a year on research … and even more to invest in those ideas.
Rather, lives like yours and mine … individuals who have the opportunity to get in BEFORE venture capitalists and deep-pocketed institutions.
That’s all thanks to Regulation Crowdfunding.
And just last week, we saw a shining example of how a scrappy startup is about to get its own golden ticket.
One of the earliest startups I invested in, BeatBox Beverages, is on the verge of getting acquired by Anheuser-Busch (BUD) in a potential $700 million deal.
You’ll recall that I got into BeatBox alongside “Shark Tank’s” Mark Cuban … back when the company was worth about $7 million.
So, for those who have been along for the ride for the last five or so years, that will be a nice reward.
Not just for the startup itself. But for everyone who took an early stake.
This is another type of “exit” I’m hoping to see more of. As you can see, to get in at a $7 million valuation and see headlines about a $700 million one feels great.
Just last week, I walked you through how I think about IPOs. Those can come with just as large of gains for early investors like us, even if IPO investors themselves don’t always see similar returns.
Now, that BeatBox deal pre-dated my time at Weiss Ratings.
But ever since then, I’ve been on the lookout for startups that measure up to it.
BeatBox certainly set a high bar in general. But now with that kind of pending “exit” ahead for its earliest shareholders …
It’s going to take even more to impress me when it comes to future deals!
That said …
Not only do I believe I’ve just found another extremely promising early-stage startup …
But, at 2 p.m. Eastern TODAY, I plan to share details about it!
It’s a company that’s made what I like to call an Ozempic-level discovery.
The Journal of Medicinal Chemistry calls it “a paradigm shift in drug discovery” …
And The Lancet, one of the world’s most prestigious medical journals, says, “This single innovation has upended decades of pharmaceutical thinking …”
This revolution has produced life-changing gains for early investors, with returns in excess of 30,000% …
If you haven’t yet secured your spot at my brand-new Private Investor Briefing, no worries!
You can do that right now here.
I hope you’ll join me there.
And that you’ll follow the steps at the end of the presentation.
Either way, I just want to say thank you.
I’ve been on the road more days than not over the past couple of months.
And I’m looking forward to having a few days to reflect on how far we’ve come together here … and how far we can go.
Again, I couldn’t do what I do without you.
And I’m grateful that, when it comes to your own decision-making, you continue to put your trust in me.
While gratitude is something we should all practice every day, it reminds me that the right mindset is key to success.
So if you’re looking for a bit of a boost in resetting your investment mindset, now is a great time to do just that.
Happy hunting!
Chris Graebe
